Hidden culprit: Human metapneumovirus identified in severe adult pneumonia case

Severe pneumonia caused by human metapneumovirus in an immunocompetent adult highlights diagnostic challenges and underscores the need for rapid molecular diagnostics to improve outcomes.

Opinion | ‘They Don’t Play by Our Rules’: What We Heard This Week

“Hospitals are eating up practices all around us … and guess what? They don’t play by our rules.” — Mohammad Ibrahim, DO, of the Michigan

November 20, 2023

Zenas BioPharma and BMS enter antibody development deal

BMS will obtain exclusive rights for the development and marketing of obexelimab in licensed regions. Credit: Stock-Asso / Shutterstock.com. Zenas BioPharma and Bristol Myers Squibb

September 6, 2023

Lawsuit to fix pulse oximeter bias makes progress with device manufacturers

In 2022, Noha Aboelata noticed something troubling. The founding CEO of a health clinic that serves a predominantly Black and brown population, she realized that

November 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.